|
Published today; data on apabetalone in CKD
|
6
|
Resverlogix Corp.
|
Jun 08, 2023 01:01PM
|
|
Re: CRISPR screen identifies COVID19 enabling genes
|
6
|
Resverlogix Corp.
|
Jun 24, 2020 04:41PM
|
|
Re: Long time that we’ve seen a post!
|
6
|
Resverlogix Corp.
|
Oct 20, 2023 01:22PM
|
|
Published 8 days ago; review article out of Qatar Univ.
|
6
|
Resverlogix Corp.
|
Feb 14, 2024 01:08PM
|
|
Lets go science...
|
6
|
Resverlogix Corp.
|
Nov 02, 2022 12:42PM
|
|
Re: Surf's up
|
7
|
Resverlogix Corp.
|
Feb 06, 2020 09:41PM
|
|
Re: 0.05 P-values -- A bridge too far ?
|
7
|
Resverlogix Corp.
|
Feb 13, 2020 10:01PM
|
|
Re: fish oil and bleeding
|
7
|
Resverlogix Corp.
|
Nov 12, 2019 11:49AM
|
|
Re: New Publication Conclusion
|
7
|
Resverlogix Corp.
|
Mar 01, 2023 12:43PM
|
|
Re: eGFR and Cognition: Correction:
|
8
|
Resverlogix Corp.
|
Nov 23, 2019 02:47PM
|
|
CVD, kidneys, and doctors... oh my!
|
9
|
Resverlogix Corp.
|
Nov 19, 2019 02:28PM
|
|
Re: 0.05 P-values -- A bridge too far ?
|
9
|
Resverlogix Corp.
|
Feb 12, 2020 01:40PM
|
|
Re: Just back from IR,...
|
9
|
Resverlogix Corp.
|
Oct 26, 2019 05:33PM
|
|
Review article on epigenetics and references apabetalone a lot; exposure.
|
9
|
Resverlogix Corp.
|
Feb 06, 2023 10:48AM
|
|
Re: eGFR and Cognition?
|
10
|
Resverlogix Corp.
|
Nov 22, 2019 12:28PM
|
|
Re: Looking for clues:
|
11
|
Resverlogix Corp.
|
Nov 30, 2019 01:24AM
|
|
Re: Recent publications:
|
11
|
Resverlogix Corp.
|
Sep 28, 2023 01:13PM
|
|
Re: GROWACET - OTC?
|
11
|
Resverlogix Corp.
|
Oct 16, 2019 01:25PM
|
|
Recent publications:
|
11
|
Resverlogix Corp.
|
Sep 26, 2023 01:07PM
|
|
Re: Estimated Glomerular Filtration Rate
|
12
|
Resverlogix Corp.
|
Nov 17, 2019 07:21PM
|
